Dynamics of behavioral disorders in transgenic mice with modeled Alzheimer's disease

Bulletin of Experimental Biology and Medicine
I I SeminaA L Zefirov

Abstract

Age-related development of behavioral disorders in transgenic mice with modeled Alzheimer's disease carrying V6S3-Tg(APP695)85Dbo Tg(PSENI)85Dbo) genotype was assessed at the age of 7.5, 10 and 20 months in the following tests: open-field, plus maze, T-maze, conditioned passive avoidance response, rotarod, conflict situation with water deprivation, behavioral despair, and arecoline tremor. The main behavioral disorder in transgenic mice at all observation terms was memory impairment in conditioning with positive (but not negative) reinforcement. At the age of 7.5 and 10 months, transgenic mice also showed signs of nonspecific excitement and anxiety, depression-like state, and symptoms of cholinergic deficit. Our results suggest that appropriate age for behavioral tests in studies of effects of potential anti-Alzheimer drugs in transgenic V6S3-Tg(APP695)85Dbo Tg(PSENI)85Dbo) mice is 7.5-10 months.

References

Aug 2, 1996·The Journal of Biological Chemistry·D J Selkoe
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ramiz M SalimovInga I Poletaeva
May 28, 2004·Briefings in Functional Genomics & Proteomics·Karen Duff, Faraha Suleman
Apr 5, 2007·Nature Protocols·Robert M J Deacon
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Feb 9, 2010·The FEBS Journal·Ola PhilipsonLars N G Nilsson
Nov 12, 2013·Neurochemistry International·Marat Alexandrovich MukhamedyarovAndrás Palotás

❮ Previous
Next ❯

Citations

Nov 15, 2015·Acta Neuropathologica Communications·Guilian XuDavid R Borchelt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.